全体要約
うっ血性心不全（CHF）は心筋のポンピング効率に悪影響を及ぼす生理的状態であり、心臓周辺に液体が蓄積されることが特徴です。2022年の世界のうっ血性心不全（CHF）処理装置市場規模は4875.8百万米ドルで、2029年には6085.2百万米ドルに成長すると予測されています。市場成長の要因には、生活習慣の変化や技術革新、早期介入の重要性が挙げられます。
うっ血性心不全（CHF）処理装置は、心臓のリズムを維持するためのデバイスであり、心臓再同期療法（CRT）や植込み型除細動器（ICD）などが含まれます。市場は地域別に分かれており、アメリカ、アジア太平洋、ヨーロッパ、中東・アフリカの各地域での成長機会が存在します。政府の規制や高コスト、薬物治療の優先度が市場成長の制約要因となっています。
関連する質問
4875.8百万米ドル（2022年）
CAGR 6085.2（2023年から2029年）
Abiomed, Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Jarvik Heart, LivaNova PLC, Medtronic, ReliantHeart, Abbott
ライフスタイル習慣の変化, 技術革新の増加, 早期介入と一次予防の強調
概要
LPI (LP Information)の最新の調査報告書「心不全（CHF）治療機器産業予測」では、過去の販売を見ながら、2022年の全世界の心不全（CHF）治療機器の売上をレビューし、2023年から2029年までの心不全（CHF）治療機器の売上予測を地域および市場セクター別に包括的に分析しています。心不全（CHF）治療機器の売上が地域、市場セクター、サブセクターごとに分解されており、この報告書では、全世界の心不全（CHF）治療機器産業に関する詳細な分析を百万米ドル単位で提供。
このインサイトレポートは、世界の充血性心不全（CHF）治療機器の状況に関する包括的な分析を提供し、製品のセグメンテーション、企業の形成、収益、市場シェア、最新の開発およびM&A活動に関する重要なトレンドを強調しています。また、このレポートでは、充血性心不全（CHF）治療機器のポートフォリオと能力、市場参入戦略、市場ポジション、および地理的な範囲に焦点を当てながら、主要なグローバル企業の戦略も分析し、加速する世界の充血性心不全（CHF）治療機器市場におけるこれらの企業の独自の位置をよりよく理解することを目指しています。
このインサイトレポートは、心不全（CHF）治療デバイスのグローバルな展望を形成する主要な市場トレンド、ドライバー、および影響要因を評価し、タイプ、アプリケーション、地理、そして市場規模別に予測を分解して、新たな機会のポケットを浮き彫りにします。数百のボトムアップの定性的および定量的市場インプットに基づく透明な方法論により、この調査予測は、心不全（CHF）治療デバイスの現在の状態と将来の軌道に関する非常に詳細かつニュアンスのある見解を提供します。
グローバルなうっ血性心不全（CHF）治療機器市場の規模は、2022年の48億7580万米ドルから2029年には60億8520万米ドルに成長する見込みです。そして、2023年から2029年にかけてCAGRが6085.2を成長すると予想されています。
これは、健康的でない食生活、過度のアルコール摂取、喫煙、肥満、身体活動の不足など、常に変化するライフスタイル習慣によるものです。このため、個人が不整脈や心不全にかかりやすくなっています。さらに、CHF治療機器の技術革新の数が多く、これらの機器の採用率が高まり、心疾患の早期介入と一次予防への重視が市場を牽引している要因です。逆に、CHF治療機器の承認に関する厳しい政府規制や、高コスト、CHF治療薬への高い志向が市場の成長を抑制している要因の一部です。
このレポートは、製品タイプ、アプリケーション、主要メーカー、主要地域と国ごとのうっ血性心不全（CHF）治療デバイス市場の包括的な概要、市場シェア、および成長機会を提供します。
市場細分化:
種類によるセグメンテーション
心臓再同期療法 (CRT)
植込み型除細動器 (ICD)
アプリケーション別のセグメンテーション
左心室補助装置 (LVAD)
右心室補助装置 (RVAD)
両心室補助装置 (BIVAD)
このレポートでは、市場を地域別に分けています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東及びアフリカ
エジプト
南アフリカ
イスラエル
トルコ
湾岸協力理事会（GCC）諸国
以下に紹介する企業は、プライマリーエキスパートから収集した情報と、企業のカバレッジ、製品ポートフォリオ、市場浸透率を分析した結果に基づいて選ばれました。
アビモード
ベルリンハート株式会社
バイオトロニク SE & Co. KG
ボストン・サイエンティフィック・コーポレーション
ハートウェアインターナショナル
ジャーヴィックハート
リバノバPLC
メドトロニック
リライアントハート
アボット
このレポートで扱われた重要な質問
世界の充血性心不全（CHF）治療機器市場の10年展望はどのようなものですか？
うっ血性心不全（CHF）治療デバイス市場の成長を推進している要因は何ですか？世界的および地域別に。
どの技術が市場と地域ごとに最も速い成長を遂げるのでしょうか？
充血性心不全（CHF）治療デバイス市場の機会は、最終市場の規模によってどのように異なりますか？
充血性心不全（CHF）治療デバイスは、種類や用途によってどのように分かれていますか？
COVID-19とロシア・ウクライナ戦争の影響は何ですか？
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルのうっ血性心不全（CHF）処理装置、年間売上、2018年～2029年
2.1.2 うっ血性心不全（CHF）処理装置の世界市場の現状分析・将来予測、地理別、2018年、2022年および2029年
2.1.3 うっ血性心不全（CHF）処理装置の世界市場の現状分析・将来予測、国・地域別、2018年、2022年および2029年
2.2 うっ血性心不全（CHF）処理装置セグメント、タイプ別
2.2.1 心臓再同期療法（CRT）
2.2.2 植込み型除細動器(ICD)
2.3 うっ血性心不全（CHF）処理装置の売上、タイプ別
2.3.1 グローバルにおけるうっ血性心不全（CHF）処理装置の売上・市場シェア、タイプ別（2018年～2023年）
2.3.2 うっ血性心不全（CHF）処理装置のグローバルレベニュー・市場シェア、タイプ別（2018～2023年）
2.3.3 グローバルのうっ血性心不全（CHF）処理装置、販売価格（タイプ別）（2018年～2023年）
2.4 うっ血性心不全（CHF）処理装置セグメント、用途別
2.4.1 左心室補助装置（LVAD）
2.4.2 右心室アシスト装置(RVAD)
2.4.3 両心室アシスト装置（BIVAD）
2.5 うっ血性心不全（CHF）処理装置の売上、用途別
2.5.1 グローバルのうっ血性心不全（CHF）処理装置、収益・市場シェア（用途別）（2018年～2023年）
2.5.2 うっ血性心不全（CHF）処理装置のグローバルレベニュー・市場シェア、用途別（2018～2023年）
2.5.3 グローバルのうっ血性心不全（CHF）処理装置、販売価格（用途別）（2018年～2023年）
3 グローバルにおけるうっ血性心不全（CHF）処理装置、企業別
3.1 グローバルにおけるうっ血性心不全（CHF）処理装置市場のブレークダウンデータ、企業別
3.1.1 グローバルにおけるうっ血性心不全（CHF）処理装置の年間売上、企業別（2018年～2023年）
3.1.2 グローバルにおけるうっ血性心不全（CHF）処理装置の売上・市場シェア、企業別（2018年～2023年）
3.2 グローバルにおけるうっ血性心不全（CHF）処理装置の年間収益、企業別（2018年～2023年）
3.2.1 グローバルにおけるうっ血性心不全（CHF）処理装置市場の収益規模、企業別（2018年～2023年）
3.2.2 グローバルにおけるうっ血性心不全（CHF）処理装置市場の収益シェア、企業別（2018年～2023年）
3.3 グローバルにおけるうっ血性心不全（CHF）処理装置の販売価格、企業別
3.4 うっ血性心不全（CHF）処理装置の主要メーカー、生産地域分布、販売地域、製品タイプ
3.4.1 うっ血性心不全（CHF）処理装置の主要メーカー、製品と拠点の分布
3.4.2 プレイヤーが提供しているうっ血性心不全（CHF）処理装置製品
3.5 市場集中度分析
3.5.1 競合情勢分析
3.5.2 集中度レシオ（CR3、CR5、CR10）（2018年～2023年）
3.6 新製品・潜在的参入
3.7 M&A、拡大
4 うっ血性心不全（CHF）処理装置の世界市場過去推移レビュー、地理別
4.1 うっ血性心不全（CHF）処理装置の世界市場規模の過去推移、地理別（2018年～2023年）
4.1.1 グローバルにおけるうっ血性心不全（CHF）処理装置の年間売上、地理別（2018年～2023年）
4.1.2 グローバルにおけるうっ血性心不全（CHF）処理装置の年間収益、地理別（2018年～2023年）
4.2 うっ血性心不全（CHF）処理装置の世界市場規模の過去推移、国・地域別（2018年～2023年）
4.2.1 グローバルにおけるうっ血性心不全（CHF）処理装置の年間売上、国・地域別（2018年～2023年）
4.2.2 グローバルにおけるうっ血性心不全（CHF）処理装置の年間収益、国・地域別（2018年～2023年）
4.3 アメリカズにおけるうっ血性心不全（CHF）処理装置の売上成長
4.4 APACにおけるうっ血性心不全（CHF）処理装置の売上成長
4.5 ヨーロッパにおけるうっ血性心不全（CHF）処理装置の売上成長
4.6 中東・アフリカにおけるうっ血性心不全（CHF）処理装置の売上成長
5 アメリカズ
5.1 アメリカズにおけるうっ血性心不全（CHF）処理装置の売上、国別
5.1.1 アメリカズにおけるうっ血性心不全（CHF）処理装置の売上規模、国別（2018年～2023年）
5.1.2 アメリカズにおけるうっ血性心不全（CHF）処理装置市場の収益規模、国別（2018年～2023年）
5.2 アメリカズにおけるうっ血性心不全（CHF）処理装置の売上、タイプ別
5.3 アメリカズにおけるうっ血性心不全（CHF）処理装置の売上、用途別
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおけるうっ血性心不全（CHF）処理装置の売上、地域別
6.1.1 APACにおけるうっ血性心不全（CHF）処理装置の売上規模、地域別（2018年～2023年）
6.1.2 APACにおけるうっ血性心不全（CHF）処理装置市場の収益規模、地域別（2018年～2023年）
6.2 APACにおけるうっ血性心不全（CHF）処理装置の売上、タイプ別
6.3 APACにおけるうっ血性心不全（CHF）処理装置の売上、用途別
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
6.10 中国の台湾
7 ヨーロッパ
7.1 ヨーロッパにおけるうっ血性心不全（CHF）処理装置、国別
7.1.1 ヨーロッパにおけるうっ血性心不全（CHF）処理装置の売上規模、国別（2018年～2023年）
7.1.2 ヨーロッパにおけるうっ血性心不全（CHF）処理装置市場の収益規模、国別（2018年～2023年）
7.2 ヨーロッパにおけるうっ血性心不全（CHF）処理装置の売上、タイプ別
7.3 ヨーロッパにおけるうっ血性心不全（CHF）処理装置の売上、用途別
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカにおけるうっ血性心不全（CHF）処理装置、国別
8.1.1 中東・アフリカにおけるうっ血性心不全（CHF）処理装置の売上規模、国別（2018年～2023年）
8.1.2 中東・アフリカにおけるうっ血性心不全（CHF）処理装置市場の収益規模、国別（2018年～2023年）
8.2 中東・アフリカにおけるうっ血性心不全（CHF）処理装置の売上、タイプ別
8.3 中東・アフリカにおけるうっ血性心不全（CHF）処理装置の売上、用途別
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 製造コスト構造分析
10.1 原料・サプライヤー
10.2 うっ血性心不全（CHF）処理装置の製造コスト構造分析
10.3 うっ血性心不全（CHF）処理装置の製造プロセス分析
10.4 うっ血性心不全（CHF）処理装置のインダストリーチェーン構造
11 マーケティング・流通・顧客
11.1 販売チャネル
11.1.1 直接チャネル
11.1.2 間接チャネル
11.2 うっ血性心不全（CHF）処理装置の流通業者
11.3 うっ血性心不全（CHF）処理装置の顧客
12 うっ血性心不全（CHF）処理装置の世界市場予測レビュー、地理別
12.1 グローバルにおけるうっ血性心不全（CHF）処理装置の市場規模予測、地域別
12.1.1 グローバルのうっ血性心不全（CHF）処理装置、市場予測（地域別）（2024年～2029年）
12.1.2 グローバルのうっ血性心不全（CHF）処理装置、年間収益予測（地域別）（2024年～2029年）
12.2 アメリカズにおける予測、国別
12.3 APACにおける予測、地域別
12.4 ヨーロッパにおける予測、国別
12.5 中東・アフリカにおける予測、国別
12.6 グローバルにおけるうっ血性心不全（CHF）処理装置の市場予測、タイプ別
12.7 グローバルにおけるうっ血性心不全（CHF）処理装置の市場予測、用途別
13 キープレイヤー分析
13.1 Abiomed
13.1.1 Abiomed：企業情報
13.1.2 Abiomed：うっ血性心不全（CHF）処理装置製品ポートフォリオと特徴
13.1.3 Abiomed：うっ血性心不全（CHF）処理装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.1.4 Abiomed：主要事業概要
13.1.5 Abiomed：直近の展開
13.2 Berlin Heart GmbH
13.2.1 Berlin Heart GmbH：企業情報
13.2.2 Berlin Heart GmbH：うっ血性心不全（CHF）処理装置製品ポートフォリオと特徴
13.2.3 Berlin Heart GmbH：うっ血性心不全（CHF）処理装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.2.4 Berlin Heart GmbH：主要事業概要
13.2.5 Berlin Heart GmbH：直近の展開
13.3 Biotronik SE & Co\. KG
13.3.1 Biotronik SE & Co\. KG：企業情報
13.3.2 Biotronik SE & Co\. KG：うっ血性心不全（CHF）処理装置製品ポートフォリオと特徴
13.3.3 Biotronik SE & Co\. KG：うっ血性心不全（CHF）処理装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.3.4 Biotronik SE & Co\. KG：主要事業概要
13.3.5 Biotronik SE & Co\. KG：直近の展開
13.4 Boston Scientific Corporation
13.4.1 Boston Scientific Corporation：企業情報
13.4.2 Boston Scientific Corporation：うっ血性心不全（CHF）処理装置製品ポートフォリオと特徴
13.4.3 Boston Scientific Corporation：うっ血性心不全（CHF）処理装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.4.4 Boston Scientific Corporation：主要事業概要
13.4.5 Boston Scientific Corporation：直近の展開
13.5 HeartWare International
13.5.1 HeartWare International：企業情報
13.5.2 HeartWare International：うっ血性心不全（CHF）処理装置製品ポートフォリオと特徴
13.5.3 HeartWare International：うっ血性心不全（CHF）処理装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.5.4 HeartWare International：主要事業概要
13.5.5 HeartWare International：直近の展開
13.6 Jarvik Heart
13.6.1 Jarvik Heart：企業情報
13.6.2 Jarvik Heart：うっ血性心不全（CHF）処理装置製品ポートフォリオと特徴
13.6.3 Jarvik Heart：うっ血性心不全（CHF）処理装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.6.4 Jarvik Heart：主要事業概要
13.6.5 Jarvik Heart：直近の展開
13.7 LivaNova PLC
13.7.1 LivaNova PLC：企業情報
13.7.2 LivaNova PLC：うっ血性心不全（CHF）処理装置製品ポートフォリオと特徴
13.7.3 LivaNova PLC：うっ血性心不全（CHF）処理装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.7.4 LivaNova PLC：主要事業概要
13.7.5 LivaNova PLC：直近の展開
13.8 Medtronic
13.8.1 Medtronic：企業情報
13.8.2 Medtronic：うっ血性心不全（CHF）処理装置製品ポートフォリオと特徴
13.8.3 Medtronic：うっ血性心不全（CHF）処理装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.8.4 Medtronic：主要事業概要
13.8.5 Medtronic：直近の展開
13.9 ReliantHeart
13.9.1 ReliantHeart：企業情報
13.9.2 ReliantHeart：うっ血性心不全（CHF）処理装置製品ポートフォリオと特徴
13.9.3 ReliantHeart：うっ血性心不全（CHF）処理装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.9.4 ReliantHeart：主要事業概要
13.9.5 ReliantHeart：直近の展開
13.10 Abbott
13.10.1 Abbott：企業情報
13.10.2 Abbott：うっ血性心不全（CHF）処理装置製品ポートフォリオと特徴
13.10.3 Abbott：うっ血性心不全（CHF）処理装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.10.4 Abbott：主要事業概要
13.10.5 Abbott：直近の展開
14 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
LPI (LP Information)' newest research report, the “Congestive Heart Failure (CHF) Treatment Devices Industry Forecast” looks at past sales and reviews total world Congestive Heart Failure (CHF) Treatment Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Congestive Heart Failure (CHF) Treatment Devices sales for 2023 through 2029. With Congestive Heart Failure (CHF) Treatment Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Congestive Heart Failure (CHF) Treatment Devices industry.
This Insight Report provides a comprehensive analysis of the global Congestive Heart Failure (CHF) Treatment Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Congestive Heart Failure (CHF) Treatment Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Congestive Heart Failure (CHF) Treatment Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Congestive Heart Failure (CHF) Treatment Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Congestive Heart Failure (CHF) Treatment Devices.
The global Congestive Heart Failure (CHF) Treatment Devices market size is projected to grow from US$ 4875.8 million in 2022 to US$ 6085.2 million in 2029; it is expected to grow at a CAGR of 6085.2 from 2023 to 2029.
This is primarily attributed to the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure. In addition, a number of factors such as the large number of technological advancements in CHF treatment devices, increased adoption rate of these devices, and rising emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market. Conversely, stringent government regulations for the approval of CHF treatment devices, high cost of, and high preference to drugs for CHF treatment are some of the factors restraining the market growth.
This report presents a comprehensive overview, market shares, and growth opportunities of Congestive Heart Failure (CHF) Treatment Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)
Segmentation by application
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
Abbott
Key Questions Addressed in this Report
What is the 10-year outlook for the global Congestive Heart Failure (CHF) Treatment Devices market?
What factors are driving Congestive Heart Failure (CHF) Treatment Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Congestive Heart Failure (CHF) Treatment Devices market opportunities vary by end market size?
How does Congestive Heart Failure (CHF) Treatment Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Country/Region, 2018, 2022 & 2029
2.2 Congestive Heart Failure (CHF) Treatment Devices Segment by Type
2.2.1 Cardiac Resynchronization Therapy (CRT)
2.2.2 Implantable Cardioverter Defibrillators (ICDs)
2.3 Congestive Heart Failure (CHF) Treatment Devices Sales by Type
2.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Type (2018-2023)
2.4 Congestive Heart Failure (CHF) Treatment Devices Segment by Application
2.4.1 Left Ventricular Assist Device (LVAD)
2.4.2 Right Ventricular Assist Device (RVAD)
2.4.3 Biventricular Assist Device (BIVAD)
2.5 Congestive Heart Failure (CHF) Treatment Devices Sales by Application
2.5.1 Global Congestive Heart Failure (CHF) Treatment Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Application (2018-2023)
3 Global Congestive Heart Failure (CHF) Treatment Devices by Company
3.1 Global Congestive Heart Failure (CHF) Treatment Devices Breakdown Data by Company
3.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Annual Sales by Company (2018-2023)
3.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company (2018-2023)
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2018-2023)
3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company (2018-2023)
3.3 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Company
3.4 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Location Distribution
3.4.2 Players Congestive Heart Failure (CHF) Treatment Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region
4.1 World Historic Congestive Heart Failure (CHF) Treatment Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Congestive Heart Failure (CHF) Treatment Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Congestive Heart Failure (CHF) Treatment Devices Sales Growth
4.4 APAC Congestive Heart Failure (CHF) Treatment Devices Sales Growth
4.5 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Growth
4.6 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Growth
5 Americas
5.1 Americas Congestive Heart Failure (CHF) Treatment Devices Sales by Country
5.1.1 Americas Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023)
5.1.2 Americas Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2023)
5.2 Americas Congestive Heart Failure (CHF) Treatment Devices Sales by Type
5.3 Americas Congestive Heart Failure (CHF) Treatment Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Congestive Heart Failure (CHF) Treatment Devices Sales by Region
6.1.1 APAC Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2018-2023)
6.1.2 APAC Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2018-2023)
6.2 APAC Congestive Heart Failure (CHF) Treatment Devices Sales by Type
6.3 APAC Congestive Heart Failure (CHF) Treatment Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Congestive Heart Failure (CHF) Treatment Devices by Country
7.1.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023)
7.1.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2023)
7.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type
7.3 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices by Country
8.1.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Type
8.3 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Congestive Heart Failure (CHF) Treatment Devices
10.3 Manufacturing Process Analysis of Congestive Heart Failure (CHF) Treatment Devices
10.4 Industry Chain Structure of Congestive Heart Failure (CHF) Treatment Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Congestive Heart Failure (CHF) Treatment Devices Distributors
11.3 Congestive Heart Failure (CHF) Treatment Devices Customer
12 World Forecast Review for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region
12.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Region
12.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Forecast by Region (2024-2029)
12.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Congestive Heart Failure (CHF) Treatment Devices Forecast by Type
12.7 Global Congestive Heart Failure (CHF) Treatment Devices Forecast by Application
13 Key Players Analysis
13.1 Abiomed
13.1.1 Abiomed Company Information
13.1.2 Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abiomed Main Business Overview
13.1.5 Abiomed Latest Developments
13.2 Berlin Heart GmbH
13.2.1 Berlin Heart GmbH Company Information
13.2.2 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Berlin Heart GmbH Main Business Overview
13.2.5 Berlin Heart GmbH Latest Developments
13.3 Biotronik SE & Co. KG
13.3.1 Biotronik SE & Co. KG Company Information
13.3.2 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biotronik SE & Co. KG Main Business Overview
13.3.5 Biotronik SE & Co. KG Latest Developments
13.4 Boston Scientific Corporation
13.4.1 Boston Scientific Corporation Company Information
13.4.2 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boston Scientific Corporation Main Business Overview
13.4.5 Boston Scientific Corporation Latest Developments
13.5 HeartWare International
13.5.1 HeartWare International Company Information
13.5.2 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 HeartWare International Main Business Overview
13.5.5 HeartWare International Latest Developments
13.6 Jarvik Heart
13.6.1 Jarvik Heart Company Information
13.6.2 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Jarvik Heart Main Business Overview
13.6.5 Jarvik Heart Latest Developments
13.7 LivaNova PLC
13.7.1 LivaNova PLC Company Information
13.7.2 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 LivaNova PLC Main Business Overview
13.7.5 LivaNova PLC Latest Developments
13.8 Medtronic
13.8.1 Medtronic Company Information
13.8.2 Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Medtronic Main Business Overview
13.8.5 Medtronic Latest Developments
13.9 ReliantHeart
13.9.1 ReliantHeart Company Information
13.9.2 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ReliantHeart Main Business Overview
13.9.5 ReliantHeart Latest Developments
13.10 Abbott
13.10.1 Abbott Company Information
13.10.2 Abbott Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications
13.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Abbott Main Business Overview
13.10.5 Abbott Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Congestive Heart Failure (CHF) Treatment Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Congestive Heart Failure (CHF) Treatment Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Cardiac Resynchronization Therapy (CRT) Table 4. Major Players of Implantable Cardioverter Defibrillators (ICDs) Table 5. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units) Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2023) Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2018-2023) & ($ million) Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2018-2023) Table 9. Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Type (2018-2023) & (USD/Unit) Table 10. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (K Units) Table 11. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2018-2023) Table 12. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2018-2023) Table 13. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2018-2023) Table 14. Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Application (2018-2023) & (USD/Unit) Table 15. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Company (2018-2023) & (K Units) Table 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company (2018-2023) Table 17. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2018-2023) ($ Millions) Table 18. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company (2018-2023) Table 19. Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Company (2018-2023) & (USD/Unit) Table 20. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Producing Area Distribution and Sales Area Table 21. Players Congestive Heart Failure (CHF) Treatment Devices Products Offered Table 22. Congestive Heart Failure (CHF) Treatment Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Geographic Region (2018-2023) & (K Units) Table 26. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Geographic Region (2018-2023) Table 27. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Geographic Region (2018-2023) & ($ millions) Table 28. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Geographic Region (2018-2023) Table 29. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Country/Region (2018-2023) & (K Units) Table 30. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country/Region (2018-2023) Table 31. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Country/Region (2018-2023) & ($ millions) Table 32. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country/Region (2018-2023) Table 33. Americas Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (K Units) Table 34. Americas Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2018-2023) Table 35. Americas Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2023) & ($ Millions) Table 36. Americas Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2018-2023) Table 37. Americas Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units) Table 38. Americas Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (K Units) Table 39. APAC Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2018-2023) & (K Units) Table 40. APAC Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2018-2023) Table 41. APAC Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2018-2023) & ($ Millions) Table 42. APAC Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2018-2023) Table 43. APAC Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units) Table 44. APAC Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (K Units) Table 45. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (K Units) Table 46. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2018-2023) Table 47. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2023) & ($ Millions) Table 48. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2018-2023) Table 49. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units) Table 50. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (K Units) Table 51. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2018-2023) & (K Units) Table 52. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2018-2023) Table 53. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2018-2023) & ($ Millions) Table 54. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2018-2023) Table 55. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2018-2023) & (K Units) Table 56. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2018-2023) & (K Units) Table 57. Key Market Drivers & Growth Opportunities of Congestive Heart Failure (CHF) Treatment Devices Table 58. Key Market Challenges & Risks of Congestive Heart Failure (CHF) Treatment Devices Table 59. Key Industry Trends of Congestive Heart Failure (CHF) Treatment Devices Table 60. Congestive Heart Failure (CHF) Treatment Devices Raw Material Table 61. Key Suppliers of Raw Materials Table 62. Congestive Heart Failure (CHF) Treatment Devices Distributors List Table 63. Congestive Heart Failure (CHF) Treatment Devices Customer List Table 64. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Region (2024-2029) & (K Units) Table 65. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Region (2024-2029) & ($ millions) Table 66. Americas Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Country (2024-2029) & (K Units) Table 67. Americas Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Country (2024-2029) & ($ millions) Table 68. APAC Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Region (2024-2029) & (K Units) Table 69. APAC Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Region (2024-2029) & ($ millions) Table 70. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Country (2024-2029) & (K Units) Table 71. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Country (2024-2029) & ($ millions) Table 72. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Country (2024-2029) & (K Units) Table 73. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Country (2024-2029) & ($ millions) Table 74. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2024-2029) & (K Units) Table 75. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Type (2024-2029) & ($ Millions) Table 76. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2024-2029) & (K Units) Table 77. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2024-2029) & ($ Millions) Table 78. Abiomed Basic Information, Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors Table 79. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications Table 80. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 81. Abiomed Main Business Table 82. Abiomed Latest Developments Table 83. Berlin Heart GmbH Basic Information, Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors Table 84. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications Table 85. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 86. Berlin Heart GmbH Main Business Table 87. Berlin Heart GmbH Latest Developments Table 88. Biotronik SE & Co. KG Basic Information, Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors Table 89. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications Table 90. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 91. Biotronik SE & Co. KG Main Business Table 92. Biotronik SE & Co. KG Latest Developments Table 93. Boston Scientific Corporation Basic Information, Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors Table 94. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications Table 95. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 96. Boston Scientific Corporation Main Business Table 97. Boston Scientific Corporation Latest Developments Table 98. HeartWare International Basic Information, Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors Table 99. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications Table 100. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 101. HeartWare International Main Business Table 102. HeartWare International Latest Developments Table 103. Jarvik Heart Basic Information, Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors Table 104. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications Table 105. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 106. Jarvik Heart Main Business Table 107. Jarvik Heart Latest Developments Table 108. LivaNova PLC Basic Information, Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors Table 109. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications Table 110. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 111. LivaNova PLC Main Business Table 112. LivaNova PLC Latest Developments Table 113. Medtronic Basic Information, Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors Table 114. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications Table 115. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 116. Medtronic Main Business Table 117. Medtronic Latest Developments Table 118. ReliantHeart Basic Information, Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors Table 119. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications Table 120. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 121. ReliantHeart Main Business Table 122. ReliantHeart Latest Developments Table 123. Abbott Basic Information, Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors Table 124. Abbott Congestive Heart Failure (CHF) Treatment Devices Product Portfolios and Specifications Table 125. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 126. Abbott Main Business Table 127. Abbott Latest Developments List of Figures Figure 1. Picture of Congestive Heart Failure (CHF) Treatment Devices Figure 2. Congestive Heart Failure (CHF) Treatment Devices Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Cardiac Resynchronization Therapy (CRT) Figure 10. Product Picture of Implantable Cardioverter Defibrillators (ICDs) Figure 11. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type in 2022 Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2018-2023) Figure 13. Congestive Heart Failure (CHF) Treatment Devices Consumed in Left Ventricular Assist Device (LVAD) Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Market: Left Ventricular Assist Device (LVAD) (2018-2023) & (K Units) Figure 15. Congestive Heart Failure (CHF) Treatment Devices Consumed in Right Ventricular Assist Device (RVAD) Figure 16. Global Congestive Heart Failure (CHF) Treatment Devices Market: Right Ventricular Assist Device (RVAD) (2018-2023) & (K Units) Figure 17. Congestive Heart Failure (CHF) Treatment Devices Consumed in Biventricular Assist Device (BIVAD) Figure 18. Global Congestive Heart Failure (CHF) Treatment Devices Market: Biventricular Assist Device (BIVAD) (2018-2023) & (K Units) Figure 19. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2022) Figure 20. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application in 2022 Figure 21. Congestive Heart Failure (CHF) Treatment Devices Sales Market by Company in 2022 (K Units) Figure 22. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company in 2022 Figure 23. Congestive Heart Failure (CHF) Treatment Devices Revenue Market by Company in 2022 ($ Million) Figure 24. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company in 2022 Figure 25. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Geographic Region (2018-2023) Figure 26. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Geographic Region in 2022 Figure 27. Americas Congestive Heart Failure (CHF) Treatment Devices Sales 2018-2023 (K Units) Figure 28. Americas Congestive Heart Failure (CHF) Treatment Devices Revenue 2018-2023 ($ Millions) Figure 29. APAC Congestive Heart Failure (CHF) Treatment Devices Sales 2018-2023 (K Units) Figure 30. APAC Congestive Heart Failure (CHF) Treatment Devices Revenue 2018-2023 ($ Millions) Figure 31. Europe Congestive Heart Failure (CHF) Treatment Devices Sales 2018-2023 (K Units) Figure 32. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue 2018-2023 ($ Millions) Figure 33. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales 2018-2023 (K Units) Figure 34. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue 2018-2023 ($ Millions) Figure 35. Americas Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2022 Figure 36. Americas Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2022 Figure 37. Americas Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2023) Figure 38. Americas Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2018-2023) Figure 39. United States Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 40. Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 41. Mexico Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 42. Brazil Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 43. APAC Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region in 2022 Figure 44. APAC Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Regions in 2022 Figure 45. APAC Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2023) Figure 46. APAC Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2018-2023) Figure 47. China Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 48. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 49. South Korea Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 50. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 51. India Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 52. Australia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 53. China Taiwan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 54. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2022 Figure 55. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2022 Figure 56. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2023) Figure 57. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2018-2023) Figure 58. Germany Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 59. France Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 60. UK Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 61. Italy Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 62. Russia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 63. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2022 Figure 64. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2022 Figure 65. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2018-2023) Figure 66. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2018-2023) Figure 67. Egypt Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 68. South Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 69. Israel Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 70. Turkey Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 71. GCC Country Congestive Heart Failure (CHF) Treatment Devices Revenue Growth 2018-2023 ($ Millions) Figure 72. Manufacturing Cost Structure Analysis of Congestive Heart Failure (CHF) Treatment Devices in 2022 Figure 73. Manufacturing Process Analysis of Congestive Heart Failure (CHF) Treatment Devices Figure 74. Industry Chain Structure of Congestive Heart Failure (CHF) Treatment Devices Figure 75. Channels of Distribution Figure 76. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Forecast by Region (2024-2029) Figure 77. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Region (2024-2029) Figure 78. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Type (2024-2029) Figure 79. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Type (2024-2029) Figure 80. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Application (2024-2029) Figure 81. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Application (2024-2029)
